Community-acquired pneumonia
Conditions
Interventions
intervention group:Ganluqingwen Formula
control group:None
Sponsors
The Fourth Clinical College of Xinjiang Medical University,Xinjiang Medical University Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Volunteer subjects after detailed understanding of the contents of the informed consent form; 2. Meet the diagnostic criteria for community-acquired pneumonia in Western medicine and wind-warm lung fever in Chinese medicine.
Exclusion criteria
Exclusion criteria: Case exclusion criteria 1. Patients with combination of other serious lung diseases such as pneumothorax, lung cancer, active tuberculosis, etc; 2. Patients with combination of serious cardiovascular, cerebrovascular, hepatic, renal and hematopoietic system and other primary diseases; 3. Patients with combined tumors, pregnancy, and psychiatric disorders; 4. Patients who are allergic to the traditional Chinese medicine used by the investigator; Conditions for subjects to suspend or withdraw from clinical trials (1) Serious adverse reactions occur during the trial; (2) Major errors in the clinical trial program are found in the trial or serious deviations are found in the actual implementation process, making it difficult to objectively and systematically evaluate the efficacy of the drug; (3) The competent part of the project requires the suspension of the trial; Conditions for subjects to discontinue and withdraw from clinical trials 1. Termination and shedding criteria (1) Subjects withdraw from the trial on their own for any reason; (2) If the subject's condition worsens or serious adverse reactions occur during the trial, the case may be recognized as a case of shedding after the subject's physician's judgment and with reference to the patient's wishes; (3) Loss of visit or contact due to other reasons; 2. Termination and handling of discharged cases (1) Regardless of any reason, the reason for the case should be recorded comprehensively and objectively for the record. If the case is withdrawn due to an adverse event, the corresponding treatment measures and effects should be recorded and followed up until the condition is stabilized or the event is resolved appropriately; (2) In case of withdrawal due to inability to contact the subject, etc., screenshots of the corresponding call records should be kept; (3) Fill in the "Completion Status" in the case report form. 3. Exclusion Criteria Subjects with poor compliance or incomplete records and data, which may affect the validity and safety.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| antipyretic time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood routine;Blood Gas Analysis;IL-6;Procalcitonin;Chinese Medicine Score;Pneomonia severity index,PSI;lung Computed Tomography; | — |
Countries
China
Contacts
Public ContactLi fengsen
The Fourth Clinical College of Xinjiang Medical University
Outcome results
None listed